Characteristics and outcomes of patients with diabetes mellitus selected for dual pathway inhibition in clinical practice: The XATOA registry

Patients with DM with CVD are at significantly high cardiovascular risk, and those with PAD appear to be undertreated. Real-world outcomes observed in the XATOA registry are consistent with randomized trial data, supporting the benefit of DPI in this high-risk population.